Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Clin Exp Allergy. 2013 Mar;43(3):292–303. doi: 10.1111/j.1365-2222.2012.04065.x

Table 3.

Correlations between blood eosinophil activation or expression of β2- orβ1-integrins and BAL eosinophil percentage 48 h after segmental antigen challenge before and after anti-IL-5 administration

Measurement Before anti-IL-5 After anti-IL-5
0 h (pre-challenge) 48 h post-challenge 0 h (pre-challenge) 48 h post-challenge
rs P rs P rs P rs P
KIM-127 (intermediate- and high-activity β2) 0.74 0.05 0.32 0.50 −0.31 0.50 −0.18 0.71
β2 0.62 0.09 0.05 0.91 −0.27 0.45 0.02 0.96
αM −0.20 0.58 0.38 0.31 0.24 0.51 0.15 0.68
αL 0.41 0.25 0.35 0.36 0.22 0.58 −0.02 0.96
N29 (intermediate- and high-activity β1 0.30 0.41 0.33 0.39 0.28 0.43 0.12 0.76
β1 0.25 0.49 −0.03 0.95 0.28 0.42 −0.12 0.75